DHG Pharmaceutical Stock price

Equities

DHG

VN000000DHG0

Pharmaceuticals

End-of-day quote Ho Chi Minh S.E. 07:00:00 2024-03-27 pm EDT 5-day change 1st Jan Change
116,300 VND 0.00% Intraday chart for DHG Pharmaceutical -0.34% +11.83%
Sales 2022 4,676B 187M Sales 2023 5,015B 201M Capitalization 13,598B 544M
Net income 2022 988B 39.54M Net income 2023 1,051B 42.03M EV / Sales 2022 1.91 x
Net cash position 2022 2,184B 87.37M Net cash position 2023 1,482B 59.28M EV / Sales 2023 2.42 x
P/E ratio 2022
11.6 x
P/E ratio 2023
13.4 x
Employees 2,789
Yield 2022
4.12%
Yield 2023
-
Free-Float 48.62%
More Fundamentals * Assessed data
Dynamic Chart
DHG Pharmaceutical Joint Stock Company Provides Earnings Guidance for the Fiscal Year 2024 CI
DHG Pharmaceutical Joint Stock Company Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023 CI
DHG Pharmaceutical Joint Stock Company Provides Earnings Guidance for the Fiscal Year 2024 CI
DHG Pharmaceutical Joint Stock Company Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
DHG Pharmaceutical Joint Stock Company Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
DHG Pharmaceutical Joint Stock Company Announces Change in Personnel CI
DHG Pharmaceutical Joint Stock Company Approves Cash Dividend for the Year 2022, Payable on May 12, 2023 CI
DHG Pharmaceutical Joint Stock Company Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
DHG Pharmaceutical Joint Stock Company Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
DHG Pharmaceutical Joint Stock Company Reports Earnings Results for the Fourth Quarter Ended December 31, 2022 CI
DHG Pharmaceutical Joint Stock Company Reports Earnings Results for the Full Year Ended December 31, 2022 CI
DHG Pharmaceutical Joint Stock Company Approves Executive Changes CI
DHG Pharmaceutical Joint Stock Company Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
DHG Pharmaceutical Joint Stock Company Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
DHG Pharmaceutical Joint Stock Company Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
More news
1 week-0.34%
Current month+6.70%
1 month+7.49%
3 months+14.92%
6 months-0.09%
Current year+11.83%
More quotes
1 week
115 600.00
Extreme 115600
118 500.00
1 month
108 000.00
Extreme 108000
120 500.00
Current year
103 100.00
Extreme 103100
120 500.00
1 year
91 200.00
Extreme 91200
140 000.00
3 years
78 000.00
Extreme 78000
142 500.00
5 years
72 400.00
Extreme 72400
142 500.00
10 years
40 000.00
Extreme 40000
142 500.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 57 -
Director of Finance/CFO - -
Chief Operating Officer 49 00-02-29
Members of the board TitleAgeSince
Director/Board Member 68 16-08-14
Chief Operating Officer 49 00-02-29
Corporate Officer/Principal 64 89-08-31
More insiders
Date Price Change Volume
24-03-28 116,300 0.00% 17,800
24-03-27 116,300 -0.43% 15,700
24-03-26 116,800 +0.43% 18,500
24-03-25 116,300 +0.09% 16,600
24-03-22 116,200 -0.43% 18,100

End-of-day quote Ho Chi Minh S.E., March 27, 2024

More quotes
DHG Pharmaceutical Joint Stock Company is a Vietnam-based company engaged in the pharmaceutical industry. The Company manufactures and markets pharmaceutical products, vitamins, supplements and cosmetics. Via its subsidiaries, the Company is also involved in packaging printing, herb cultivation, medicinal supplies trading, as well as domestic travel tour and medical clinic operation.
More about the company
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
116,300 VND
Average target price
123,877 VND
Spread / Average Target
+6.52%
Consensus

Annual profits - Rate of surprise

  1. Stock
  2. Equities
  3. Stock DHG Pharmaceutical - Ho Chi Minh S.E.